AI At The Frontier: Empowering Early Career Professionals In Drug Discovery
Elrig
APRIL 29, 2024
Inspired by her time at GSK, Millie pursued a PhD at the University of Cambridge investigating the signalling pathways that drive cancer cell growth using in-vitro cell based assays and biochemical analysis. Driven by an interest in drug discovery Millie joined AstraZeneca after completion of her PhD at the end of 2020.
59 
Let's personalize your content